Ingenol 3-angelate

Ingenol 3-angelate is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 455 references associated with Ingenol 3-angelate in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Ingenol 3-angelate

Download all related citations
Per page 10 20 50 100 | Total 138
Authors Title Published Journal PubMed Link
Mühlstädt M Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient. 2016 Dermatology (Basel) pmid:27513345
Gaide O and Cattin V Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis. 2016 Dermatology (Basel) pmid:27513756
Tzika E et al. Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis. 2016 Dermatology (Basel) pmid:27513668
Stieger M and Hunger RE Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome. 2016 Dermatology (Basel) pmid:27513585
Gadaldi K et al. Ingenol Mebutate for Lentigo Maligna: A Case Report. 2016 Dermatology (Basel) pmid:27513527
Alkhalaf A and Hofbauer GF Ingenol Mebutate 150 mg as Physician-Directed Treatment of Bowen's Disease Under Occlusion. 2016 Dermatology (Basel) pmid:27512986
Le TT et al. IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate. 2016 PLoS ONE pmid:27100888
Bhandari PR and Pai VV Could ingenol mebutate be useful in managing nonmelanoma skin cancers? 2015 Apr-Jun Indian J Cancer pmid:26853424
Freiberger SN et al. Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2. 2015 Mol. Cancer Ther. pmid:26116359
Soini EJ et al. Cost-utility of first-line actinic keratosis treatments in Finland. 2015 Adv Ther pmid:26006101

Table of Content